Research Tracker›Biomarker Atlas›Marker Pages›Interleukin-6 (IL-6)

Interleukin-6 (IL-6) across conditions

Interleukin-6 (IL-6) appears in 11 entries of the OSMF biomarker atlas, covering Atrial Fibrillation, Epilepsy, Gulf War Illness, Long COVID, Low Back Pain, Lyme Disease, ME/CFS, Major Depressive Disorder, Migraine, PACVS, Rheumatoid Arthritis. Across those entries it is elevated in 9, mixed in 2. Because the same marker shifts in several unrelated conditions, it is best understood as a signal of shared biology such as inflammation, vascular or metabolic stress rather than as a condition-specific test. Each row below links to a page with the comparison group, associated symptoms, test details and primary citation.

Atrial FibrillationEpilepsyGulf War IllnessLong COVIDLow Back PainLyme DiseaseME/CFSMajor Depressive DisorderMigrainePACVSRheumatoid Arthritis

Where Interleukin-6 (IL-6) is reported

Also listed as: IL-6; Interleukin-6; Pro-inflammatory cytokine

ConditionDirectionCompared againstAssociated symptomsSource
Atrial Fibrillation↕ inconsistentAF patients vs. implied healthy/reference—Oikonomou et al. 2019
Epilepsy↑ elevatednot explicitly named (comparison implied by disease state vs. normal/control)acute encephalopathy in Dravet syndromeTsuji et al. 2011
Gulf War Illness↑ elevatedhealthy Gulf War veteran controlsSystemic inflammationJohnson et al. 2016
Long COVID↑ elevatedhealthy controls, recovered individuals without persistent symptomsFatigue, systemic inflammationLai et al. 2023
Low Back Pain↑ elevatedchronic nonspecific LBP vs asymptomatic controls—Injeyan et al. 2025
Lyme Disease↑ elevatedhealthy controlsActive Borrelia infectionSoloski et al. 2014
Major Depressive Disorder↑ elevatedfemales with depression vs healthy female controls—Jarkas et al. 2024
ME/CFS↕ inconsistenthealthy controlsSystemic inflammation, variableCorbitt et al. 2019
Migraine↑ elevatedheadache-free controls—Empl et al. 2003
PACVS↑ elevatedhealthy controlsElevated in >80% of PACVS registry cohortMundorf et al. 2024
Rheumatoid Arthritis↑ elevatedRA vs healthy (established inflammatory pathway/drug target)—Qin et al. 2022

Frequently asked questions

In which conditions is Interleukin-6 (IL-6) altered?

In the OSMF atlas Interleukin-6 (IL-6) is reported in Atrial Fibrillation, Epilepsy, Gulf War Illness, Long COVID, Low Back Pain, Lyme Disease, ME/CFS, Major Depressive Disorder, Migraine, PACVS, Rheumatoid Arthritis. It is elevated in 9, mixed in 2 across 11 entries.

Does Interleukin-6 (IL-6) point to one specific diagnosis?

No. Because Interleukin-6 (IL-6) changes in several conditions (Atrial Fibrillation, Epilepsy, Gulf War Illness, Long COVID, Low Back Pain, Lyme Disease, ME/CFS, Major Depressive Disorder, Migraine, PACVS, Rheumatoid Arthritis), an abnormal result cannot identify which condition, if any, is present. It must be interpreted with symptoms, history and other tests.

What is the LOINC code for Interleukin-6 (IL-6)?

Entries in this atlas use LOINC 26881-3. LOINC codes identify the laboratory observation so results can be compared across systems.

Is one abnormal Interleukin-6 (IL-6) result diagnostic?

No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.

Cite this page

Open Source Medicine Foundation. (2026). Interleukin-6 (IL-6) across conditions: biomarker evidence. OSMF Research Tracker. Retrieved November 14, 2026, from https://research.opensourcemed.info/biomarkers/markers/interleukin-6-il-6.html

Last reviewed: 2026-10-08 · Browse: Biomarker Index · All marker pages · Biomarker Atlas

Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.